首页> 外文期刊>American journal of medical genetics, Part A >An additional case of Hennekam lymphangiectasia-lymphedema syndrome caused by loss-of-function mutation in ADAMTS3
【24h】

An additional case of Hennekam lymphangiectasia-lymphedema syndrome caused by loss-of-function mutation in ADAMTS3

机译:Hennekam Lympangiector-Lymphedema综合征的额外案例 - Adams3中的职能职业论坛

获取原文
获取原文并翻译 | 示例
           

摘要

Hennekam lymphangiectasia-lymphedema syndrome (HKLLS) is a genetically heterogeneous lymphatic dysplasia with characteristic of facial dysmorphism, neurocognitive impairments, and abnormalities of the pericardium, intestinal tract, and extremities. It is an autosomal recessive condition caused by biallelic mutations in CCBE1 (collagen- and calcium-binding epidermal growth factor domain-containing protein 1) (HKLLS1; OMIM 235510) or FAT4 (HKLLS2; OMIM 616006). CCBE1 acts via ADAMTS3 (a disintegrin and metalloprotease with thrombospondin motifs-3 protease) to enhance vascular endothelial growth factor C signaling. There is report of one family supporting mutations in ADAMTS3 as causative for the phenotype labeled as HKLLS3. Here, we report an additional case of HKLLS that appears to be associated with homozygous nonsense mutation of ADAMTS3.
机译:Hennekam LymphangiectaIa-Lymphedema综合征(HKLLS)是一种遗传异质淋巴不良,具有面部钝化术,神经过度障碍和心包,肠道和四肢异常的特征。 它是由CCBE1(胶原和钙结合表皮生长因子域域1)的双胞胎突变引起的常染色体隐性病症(HKLLS1; OMIM 235510)或FAT4(HKLLS2; OMIM 616006)。 CCBE1通过ADAMTS3(具有血小板素蛋白基序-3蛋白酶-3蛋白酶-3蛋白酶-3蛋白酶-3蛋白酶-3蛋白酶的金属蛋白酶)起作用以增强血管内皮生长因子C信号传导。 关于Adamts3中的一个家族支持突变的报告是标记为HKLLS3的表型的致病性。 在这里,我们报告了另外一个HKLL的案例,似乎与Adamts3的纯合无意义突变有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号